NKCFO LLC’s Medifast MED Stock Holding History

NKCFO LLC’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,600	Closed	-$314K	–	139
2020 Q4	$314K	Hold	1,600	–	–	0.12%	40
2020 Q3	$263K	Buy	+1,600	New	+$263K	0.11%	40

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NKCFO LLC's MED Position: Q1 2021 in Review

NKCFO LLC sold out of Medifast (MED) in Q1 2021, closing a stake of 1,600 shares — an estimated $314K sold.

NKCFO LLC first reported a position in MED in Q3 2020 and held it in 2 quarters. The position peaked at $314K in Q4 2020. 277 funds tracked by Wall St. Rank hold MED as of Q1 2021.

NKCFO LLC reported no remaining Medifast position as of Q1 2021 after selling out during the quarter.
NKCFO LLC sold 1,600 Medifast shares in Q1 2021, an estimated $314K.
NKCFO LLC first reported a position in Medifast in Q3 2020 and held it in 2 quarters.
NKCFO LLC's Medifast position peaked at $314K in Q4 2020.
277 funds tracked by Wall St. Rank held Medifast as of Q1 2021.

Based on NKCFO LLC's 13F filing for Q1 2021, filed 3 May 2021.